Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Stoppel

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of the American Academy of Child and Adolescent Psychiatry|April 9, 2025
Prenatal Antidepressant Exposure and Risk of Depression and Anxiety Disorders: An Electronic Health Records-Based Cohort StudyArdesheer Talati, Jennifer L Vande Voort, Launia J White, et al.
JMIR Research Protocols|March 26, 2025
Treatment of Substance Use Disorders With a Mobile Phone App Within Rural Collaborative Care Management (Senyo Health): Protocol for a Mixed Methods Randomized Controlled TrialTyler S Oesterle, Nicholas L Bormann, Margaret M Paul, et al.
Frontiers in Psychiatry|May 13, 2025
The occurrence of and risk factors for depressive symptomatology in myocarditis survivors: a cross-sectional survey-based study using machine learningJean Marrero-Polanco, Laura Suarez Pardo, Shehzad K Niazi, et al.
Journal of the American Medical Informatics Association : JAMIA|May 1, 2014
An electronic health record driven algorithm to identify incident antidepressant medication usersWilliam V Bobo, Jyotishman Pathak, Hilal Maradit Kremers, et al.
Psychosomatics|December 24, 2013
Mood stability in Parkinson disease following deep brain stimulation: a 6-month prospective follow-up studyAmit Chopra, Osama A Abulseoud, Shirlene Sampson, et al.
Science Translational Medicine|May 22, 2020
Selective inhibition of glycogen synthase kinase 3α corrects pathophysiology in a mouse model of fragile X syndromePatrick K McCamphill, Laura J Stoppel, Rebecca K Senter, et al.
Journal of Affective Disorders|December 24, 2023
Clinical outcomes in the biomarkers of ketamine (Bio-K) study of open-label IV ketamine for refractory depressionSagar V Parikh, Jennifer L Vande Voort, Anastasia K Yocum, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of the American Academy of Child and Adolescent Psychiatry|April 9, 2025
Prenatal Antidepressant Exposure and Risk of Depression and Anxiety Disorders: An Electronic Health Records-Based Cohort StudyArdesheer Talati, Jennifer L Vande Voort, Launia J White, et al.
JMIR Research Protocols|March 26, 2025
Treatment of Substance Use Disorders With a Mobile Phone App Within Rural Collaborative Care Management (Senyo Health): Protocol for a Mixed Methods Randomized Controlled TrialTyler S Oesterle, Nicholas L Bormann, Margaret M Paul, et al.
Frontiers in Psychiatry|May 13, 2025
The occurrence of and risk factors for depressive symptomatology in myocarditis survivors: a cross-sectional survey-based study using machine learningJean Marrero-Polanco, Laura Suarez Pardo, Shehzad K Niazi, et al.
Journal of the American Medical Informatics Association : JAMIA|May 1, 2014
An electronic health record driven algorithm to identify incident antidepressant medication usersWilliam V Bobo, Jyotishman Pathak, Hilal Maradit Kremers, et al.
Psychosomatics|December 24, 2013
Mood stability in Parkinson disease following deep brain stimulation: a 6-month prospective follow-up studyAmit Chopra, Osama A Abulseoud, Shirlene Sampson, et al.
Science Translational Medicine|May 22, 2020
Selective inhibition of glycogen synthase kinase 3α corrects pathophysiology in a mouse model of fragile X syndromePatrick K McCamphill, Laura J Stoppel, Rebecca K Senter, et al.
Journal of Affective Disorders|December 24, 2023
Clinical outcomes in the biomarkers of ketamine (Bio-K) study of open-label IV ketamine for refractory depressionSagar V Parikh, Jennifer L Vande Voort, Anastasia K Yocum, et al.
Pageof 2